McKesson PE Ratio 2010-2025 | MCK
Current and historical p/e ratio for McKesson (MCK) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. McKesson PE ratio as of August 08, 2025 is 19.97.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| McKesson PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-08-08 |
668.58 |
|
35.51 |
| 2025-06-30 |
732.78 |
$18.83 |
38.92 |
| 2025-03-31 |
672.33 |
$25.83 |
26.03 |
| 2024-12-31 |
568.72 |
$21.84 |
26.04 |
| 2024-09-30 |
492.83 |
$19.31 |
25.52 |
| 2024-06-30 |
581.42 |
$22.36 |
26.00 |
| 2024-03-31 |
533.86 |
$22.38 |
23.85 |
| 2023-12-31 |
459.85 |
$22.07 |
20.84 |
| 2023-09-30 |
431.33 |
$25.31 |
17.04 |
| 2023-06-30 |
423.22 |
$26.81 |
15.79 |
| 2023-03-31 |
352.15 |
$25.11 |
14.02 |
| 2022-12-31 |
370.45 |
$21.87 |
16.94 |
| 2022-09-30 |
335.16 |
$14.17 |
23.65 |
| 2022-06-30 |
321.21 |
$9.46 |
33.95 |
| 2022-03-31 |
301.01 |
$7.21 |
41.75 |
| 2021-12-31 |
244.00 |
$8.89 |
27.45 |
| 2021-09-30 |
195.30 |
$-30.10 |
0.00 |
| 2021-06-30 |
186.89 |
$-28.27 |
0.00 |
| 2021-03-31 |
190.19 |
$-28.62 |
0.00 |
| 2020-12-31 |
169.17 |
$-26.92 |
0.00 |
| 2020-09-30 |
144.53 |
$13.14 |
11.00 |
| 2020-06-30 |
148.48 |
$5.61 |
26.47 |
| 2020-03-31 |
130.56 |
$5.13 |
25.45 |
| 2019-12-31 |
133.15 |
$-4.89 |
0.00 |
| 2019-09-30 |
131.18 |
$-3.52 |
0.00 |
| 2019-06-30 |
128.62 |
$2.98 |
43.16 |
| 2019-03-31 |
111.68 |
$0.06 |
1861.30 |
| 2018-12-31 |
105.07 |
$-1.35 |
0.00 |
| 2018-09-30 |
125.78 |
$0.58 |
216.86 |
| 2018-06-30 |
126.11 |
$-1.92 |
0.00 |
| 2018-03-31 |
132.86 |
$0.22 |
603.89 |
| 2017-12-31 |
146.75 |
$22.57 |
6.50 |
| 2017-09-30 |
144.22 |
$21.09 |
6.84 |
| 2017-06-30 |
154.12 |
$22.42 |
6.87 |
| 2017-03-31 |
138.64 |
$23.34 |
5.94 |
| 2016-12-31 |
131.09 |
$8.45 |
15.51 |
| 2016-09-30 |
155.33 |
$8.33 |
18.65 |
| 2016-06-30 |
173.61 |
$9.62 |
18.05 |
| 2016-03-31 |
146.04 |
$9.69 |
15.07 |
| 2015-12-31 |
182.84 |
$8.37 |
21.84 |
| 2015-09-30 |
171.27 |
$7.64 |
22.42 |
| 2015-06-30 |
207.80 |
$7.00 |
29.69 |
| 2015-03-31 |
208.88 |
$6.27 |
33.31 |
| 2014-12-31 |
191.48 |
$7.29 |
26.27 |
| 2014-09-30 |
179.37 |
$5.57 |
32.20 |
| 2014-06-30 |
171.36 |
$5.32 |
32.21 |
| 2014-03-31 |
162.28 |
$5.43 |
29.89 |
| 2013-12-31 |
148.14 |
$4.95 |
29.93 |
| 2013-09-30 |
117.58 |
$5.91 |
19.90 |
| 2013-06-30 |
104.73 |
$5.84 |
17.93 |
| 2013-03-31 |
98.57 |
$5.59 |
17.63 |
| 2012-12-31 |
88.36 |
$6.58 |
13.43 |
| 2012-09-30 |
78.23 |
$6.54 |
11.96 |
| 2012-06-30 |
85.05 |
$6.05 |
14.06 |
| 2012-03-31 |
79.45 |
$5.60 |
14.19 |
| 2011-12-31 |
70.35 |
$5.13 |
13.71 |
| 2011-09-30 |
65.48 |
$4.53 |
14.45 |
| 2011-06-30 |
75.15 |
$4.60 |
16.34 |
| 2011-03-31 |
70.85 |
$4.57 |
15.50 |
| 2010-12-31 |
62.93 |
$4.21 |
14.95 |
| 2010-09-30 |
55.09 |
$4.80 |
11.48 |
| 2010-06-30 |
59.71 |
$4.66 |
12.81 |
| 2010-03-31 |
58.27 |
$4.62 |
12.61 |
| 2009-12-31 |
55.31 |
$4.37 |
12.66 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$83.161B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
